IDTM International Journal publishes first data on the use of Polyoxidonium as preventive medicine against COVID-19
The experience of using the Russian original medication Polyoxidonium (azoximer bromide) for preventive purposes among the personnel of the "Red Zone" described by the Head of Department of infectious diseases of Cheboksary Emergency Hospital Efimov S.V. and published in a peer-reviewed international magazine (IDTM)1. The article points out that azoximer bromide can increase the effectiveness of immune defenses and reduce the risk of contracting coronavirus.
American Society of Clinical Oncology ASCO releases the data on Polyoxidonium use in cancer therapy
Data published in the peer-reviewed journal shows positive results in hospitalised COVID-19 patients
